Maria Marvich

Array ( [id] => 5834596 [patent_doc_number] => 20060246426 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-02 [patent_title] => 'Recombinant fusion proteins with high affinity binding to gold and applications thereof' [patent_app_type] => utility [patent_app_number] => 11/408634 [patent_app_country] => US [patent_app_date] => 2006-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 20130 [patent_no_of_claims] => 86 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0246/20060246426.pdf [firstpage_image] =>[orig_patent_app_number] => 11408634 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5050865 [patent_doc_number] => 20070031410 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-08 [patent_title] => 'POP2: NFkB - Inhibiting Polypeptides, Nucleic Acids and Methods of Use' [patent_app_type] => utility [patent_app_number] => 11/279043 [patent_app_country] => US [patent_app_date] => 2006-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 19837 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20070031410.pdf [firstpage_image] =>[orig_patent_app_number] => 11279043 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7692168 [patent_doc_number] => 20070231865 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-04 [patent_title] => 'Targeted deletions using retroelement-mediated placement of recombination sites' [patent_app_type] => utility [patent_app_number] => 11/391972 [patent_app_country] => US [patent_app_date] => 2006-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7977 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0231/20070231865.pdf [firstpage_image] =>[orig_patent_app_number] => 11391972 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5760702 [patent_doc_number] => 20060211647 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-21 [patent_title] => 'Nonviral vectors for delivering polynucleotides' [patent_app_type] => utility [patent_app_number] => 11/389432 [patent_app_country] => US [patent_app_date] => 2006-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 22242 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0211/20060211647.pdf [firstpage_image] =>[orig_patent_app_number] => 11389432 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4676248 [patent_doc_number] => 20080213878 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-04 [patent_title] => 'Novel human membrane proteins and polynucleotides encoding the same' [patent_app_type] => utility [patent_app_number] => 11/365756 [patent_app_country] => US [patent_app_date] => 2006-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18125 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20080213878.pdf [firstpage_image] =>[orig_patent_app_number] => 11365756 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5631511 [patent_doc_number] => 20060147980 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-06 [patent_title] => 'Methods for isolating and characterizing endogenous mRNA-protein (mRNP) complexes' [patent_app_type] => utility [patent_app_number] => 11/364485 [patent_app_country] => US [patent_app_date] => 2006-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 13982 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20060147980.pdf [firstpage_image] =>[orig_patent_app_number] => 11364485 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5732740 [patent_doc_number] => 20060257857 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-16 [patent_title] => 'Methods for identifying functionally related genes and drug targets' [patent_app_type] => utility [patent_app_number] => 11/364477 [patent_app_country] => US [patent_app_date] => 2006-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 20376 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0257/20060257857.pdf [firstpage_image] =>[orig_patent_app_number] => 11364477 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5619408 [patent_doc_number] => 20060188941 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-24 [patent_title] => 'High throughput screening assays utilizing affinity binding of green fluorescent protein' [patent_app_type] => utility [patent_app_number] => 11/360863 [patent_app_country] => US [patent_app_date] => 2006-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9975 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0188/20060188941.pdf [firstpage_image] =>[orig_patent_app_number] => 11360863 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5760077 [patent_doc_number] => 20060211022 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-21 [patent_title] => 'Detection of compounds that affect therapeutic activity' [patent_app_type] => utility [patent_app_number] => 11/361415 [patent_app_country] => US [patent_app_date] => 2006-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 16597 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0211/20060211022.pdf [firstpage_image] =>[orig_patent_app_number] => 11361415 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5677875 [patent_doc_number] => 20060183231 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-17 [patent_title] => 'Multiple-compartment eukaryotic expression systems' [patent_app_type] => utility [patent_app_number] => 11/359145 [patent_app_country] => US [patent_app_date] => 2006-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 35615 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20060183231.pdf [firstpage_image] =>[orig_patent_app_number] => 11359145 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4995096 [patent_doc_number] => 20070010441 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-11 [patent_title] => 'Random peptides that bind to gastro-intestinal tract (GIT) transport receptors and related methods' [patent_app_type] => utility [patent_app_number] => 11/356452 [patent_app_country] => US [patent_app_date] => 2006-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 48 [patent_figures_cnt] => 48 [patent_no_of_words] => 36422 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20070010441.pdf [firstpage_image] =>[orig_patent_app_number] => 11356452 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4879250 [patent_doc_number] => 20080152633 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-26 [patent_title] => 'Flavivirus Replicon Constructs for Tumor Therapy' [patent_app_type] => utility [patent_app_number] => 11/816350 [patent_app_country] => US [patent_app_date] => 2006-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 9644 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20080152633.pdf [firstpage_image] =>[orig_patent_app_number] => 11816350 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4879240 [patent_doc_number] => 20080152623 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-26 [patent_title] => 'Blockade of Airway Hyperresponsiveness and Inflammation in a Murine Model of Asthma by Insulin-Like Growth Factor Binding Protein-3 (Igfbp-3)' [patent_app_type] => utility [patent_app_number] => 11/884077 [patent_app_country] => US [patent_app_date] => 2006-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 8563 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20080152623.pdf [firstpage_image] =>[orig_patent_app_number] => 11884077 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6419821 [patent_doc_number] => 20100150884 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-17 [patent_title] => 'Anticancer Agent to Be Combined with Telomelysin' [patent_app_type] => utility [patent_app_number] => 11/884221 [patent_app_country] => US [patent_app_date] => 2006-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 12289 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0150/20100150884.pdf [firstpage_image] =>[orig_patent_app_number] => 11884221 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5608021 [patent_doc_number] => 20060269537 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-30 [patent_title] => 'Glycosyl phosphatidyl inositol specific phospholipase D proteins and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/346489 [patent_app_country] => US [patent_app_date] => 2006-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 12010 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20060269537.pdf [firstpage_image] =>[orig_patent_app_number] => 11346489 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5236567 [patent_doc_number] => 20070128724 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-07 [patent_title] => 'System for the rapid manipulation of nuculeic acid sequences' [patent_app_type] => utility [patent_app_number] => 11/340846 [patent_app_country] => US [patent_app_date] => 2006-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11214 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20070128724.pdf [firstpage_image] =>[orig_patent_app_number] => 11340846 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5706867 [patent_doc_number] => 20060195915 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-31 [patent_title] => 'Novel neurotrophic factor protein and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/330359 [patent_app_country] => US [patent_app_date] => 2006-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 25876 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0195/20060195915.pdf [firstpage_image] =>[orig_patent_app_number] => 11330359 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5533012 [patent_doc_number] => 20090232800 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-17 [patent_title] => 'E1-MINUS ADENOVIRUSES AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 11/813089 [patent_app_country] => US [patent_app_date] => 2006-01-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 25992 [patent_no_of_claims] => 83 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20090232800.pdf [firstpage_image] =>[orig_patent_app_number] => 11813089 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5648949 [patent_doc_number] => 20060134681 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-22 [patent_title] => 'Methods of assaying for compounds that inhibit premature translation termination and nonsense-mediated RNA decay' [patent_app_type] => utility [patent_app_number] => 11/318940 [patent_app_country] => US [patent_app_date] => 2005-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10330 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0134/20060134681.pdf [firstpage_image] =>[orig_patent_app_number] => 11318940 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9761711 [patent_doc_number] => 08846030 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-30 [patent_title] => 'Compounds and methods to enhance rAAV transduction' [patent_app_type] => utility [patent_app_number] => 11/301601 [patent_app_country] => US [patent_app_date] => 2005-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 36 [patent_no_of_words] => 36429 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11301601 [rel_patent_id] =>[rel_patent_doc_number] =>)